Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

InfraCredit, a ‘AAA’-rated specialised infrastructure credit guarantee institution, has announced its guarantee of Craneburg EKSG Motorway Company PLC’s N32.50 billion 20-Year Senior ...

InfraCredit, infrastructure credit guarantee institution, has announced its guarantee of Craneburg EKSG Motorway Company’s N32.50 billion 20-year Senior Guaranteed Fixed Rate Infrastructure ...

Roche became the latest drugmaker to make a multibillion dollar pledge to invest in U.S. manufacturing, announcing a $50 billion investment over the next five years on Tuesday morning. The Swiss ...

INDIANAPOLIS — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, ...

Roche is joining a big wave of companies looking to boost manufacturing in the U.S. amid trade policy coming from Washington. The biotech firm announced today it would pour $50 billion into ...

Plus, news about In­vivyd: Dana­her’s tar­iffs hit: The life sci­ences com­pa­ny cur­rent­ly ex­pects the costs of tar­iffs to be “some­thing like $350 mil­lion” in 2025 … ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose ...

Swiss Pharmaceuticals Company Roche Announces $50B Investment in US Over Next 5 Years GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the ...

Roche has announced plans to invest $50 billion in the United States over the next five years, with funds earmarked for creating new R&D sites and new and expanded manufacturing facilities.

Roche and the pharmaceutical industry as a whole are grappling with the effects of President Donald Trump’s tariffs on imports to the U.S. Drugmaker Novartis’ also plans to spend $23 billion ...